Loading...

BB Biotech AG

BBAGF•PNK
Financial Services
Asset Management
$37.79
$-10.01(-20.94%)

BB Biotech AG (BBAGF) Company Profile & Overview

Explore BB Biotech AG’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

BB Biotech AG (BBAGF) Company Profile & Overview

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.

SectorFinancial Services
IndustryAsset Management
CEODaniel Koller

Contact Information

https://www.bbbiotech.ch/en/bb-biotech
41 44 267 67 00
Seestrasse 16, Kusnacht, 8700

Company Facts

10 Employees
IPO DateOct 12, 2015
CountryCH

Frequently Asked Questions

;